Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 23, Issue 4, 2004, Pages 418-426

  Siirtola, Arja ^a   Antikainen, Marjatta ^b   Ala Houhala, Marja ^c   Solakivi, Tiina ^a,c   Jokela, Hannu ^c   Lehtimäki, Terho ^c   Holmberg, Christer ^b   Salo, Matti K ^c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COPPER; CYCLOSPORIN A; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOSUPPRESSIVE AGENT; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; ORAL GLUCOSE TOLERANCE TEST; PARTICLE SIZE; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; APOLIPOPROTEINS A; APOLIPOPROTEINS B; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; INSULIN; LIPOPROTEINS, LDL; MALE; OXIDATION-REDUCTION; PARTICLE SIZE; TRIGLYCERIDES;

EID: 1842581997     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00201-8     Document Type: Article

References (37)

1. Weis M., von Scheidt W. Cardiac allograft vasculopathy a review. Circulation. 96:1997;2069-2077.
2. Chin C., Rosenthal D., Bernstein D. Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients. Pediatr Transplant. 4:2000;193-199.
3. Ballantyne C.M. Current thinking in lipid lowering. Am J Med. 104:1998;S33-41.
4. Halevy D., Thiery J., Nagel D., et al. Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C. Arterioscler Thromb Vasc Biol. 17:1997;1432-1437.
5. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun. 6:1989;67-75.
6. Valantine H., Rickenbacker P., Kemna M., et al. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease a prospective study. Circulation. 103:2001;2144-2152.
7. Scanu A.M. The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events. Curr Cardiol Rep. 3:2001;385-390.
8. Ilveskoski E., Perola M., Lehtimaki T., et al. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men an autopsy study. Circulation. 100:1999;608-613.
9. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J. 113:1987;433-440.
10. Gylling H., Miettinen T.A. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J Lipid Res. 33:1992;1361-1371.
11. Gonzalez-Amieva A., Lopez-Miranda J., Fuentes F., Castro P., Marin C., Jimenez F.P. Genetic variations of the apolipoprotein E gene determine the plasma triglyceride levels after heart transplantation. J Heart Lung Transplant. 19:2000;765-770.
12. Laine J., Jalanko H., Leijala M., Sairanen H., Holmberg C. Kidney function in cyclosporine-treated pediatric heart transplant recipients. J Heart Lung Transplant. 16:1997;1217-1224.
13. Sorva R., Lankinen S., Tolppanen E.M., Perheentupa J. Variation of growth in height and weight of children. Acta Pediatr. 79:1990;498-506.
14. Nuutinen M.E., Turtinen J., Pokka T., et al. Obesity in children, adolescents and young adults. Ann Med. 23:1991;41-46.
15. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
16. Gaubatz J.W., Cushing G.L., Morrisett J.D. Quantitation, isolation, and characterization of human lipoprotein (a). Methods Enzymol. 129:1986;167-186.
17. Lehtimaki T., Moilanen T., Viikari J., et al. Apolipoprotein E phenotypes in Finnish youths a cross-sectional and 6-year follow-up study. J Lipid Res. 31:1990;487-495.
18. Krauss R.M., Burke D.J. Identification of multiple subfractions of plasma low density lipoproteins in normal humans. J Lipid Res. 23:1982;97-104.
19. Jaakkola O., Solakivi T., Ylä-Herttuala S., Nikkari T. Receptor-mediated binding and degradation of subfractions of human plasma low-density lipoprotein in cultured fibroblasts. Biochim Biophys Acta. 1005:1989;118-122.
20. Chung B.H., Segrest J.P., Ray M.J., et al. Single vertical spin density gradient ultracentrifugation. Methods Enzymol. 128:1986;181-209.
21. Puhl H., Waeg G., Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol. 233:1994;425-441.
22. Tritos N.A., Mantzoros C.S. Clinical review 97 syndromes of severe insulin resistance. J Clin Endocrinol Metab. 83:1998;3025-3030.
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
24. Austin M.A., King M.C., Vranizan K.M., Newman B., Krauss R.M. Inheritance of low-density lipoprotein subclass patterns results of complex segregation analysis. Am J Hum Genet. 43:1988;838-846.
25. Ghanem H., van den Dorpel M.A., Weimar W., et al. Increased low density lipoprotein oxidation in stable kidney transplant recipients. Kidney Int. 49:1996;488-493.
26. Nikkilä M., Solakivi T., Lehtimäki T., Koivula T., Laippala P., Åström B. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis. 106:1994;149-157.
27. Mykkanen L., Haffner S.M., Rainwater D.L., Karhapaa P., Miettinen H., Laakso M. Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler Thromb Vasc Biol. 17:1997;1447-1453.
28. van den Dorpel M.A., Ghanem H., Rischen-Vos J., Man in't Veld A.J., Jansen H., Weimar W. Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipients. Kidney Int. 51:1997;1608-1612.
29. Haffner S.M., Stern M.P., Miettinen H., Robbins D., Howard B.V. Apolipoprotein E polymorphism and LDL particle size in a biethnic population. Arterioscler Thromb Vasc Biol. 16:1996;1184-1188.
30. Zhao S.P., Verhoeven M.H., Vink J., et al. Relationship between apolipoprotein E and low density lipoprotein particle size. Atherosclerosis. 102:1993;147-154.
31. Awni W.M., Heim-Duthoy K., Kasiske B.L. Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients. Transplant Proc. 22:1990;1193-1196.
32. Apanay D.C., Neylan J.F., Ragab M.S., Sgoutas D.S. Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients. Transplantation. 58:1994;663-669.
33. Varghese Z., Fernando R.L., Turakhia G., et al. Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients. Kidney Int. 71:(suppl):1999;S137-140.
34. Devaraj S., Li D.J., Vazquez M., Jialal I. Cyclosporin A does not increase the oxidative susceptibility of low density lipoprotein in vitro. Free Radic Biol Med. 26:1999;1064-1068.
35. Wu T.W., Fung K.P., Wu J., Yang C.C., Weisel R.D. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol. 51:1996;859-862.
36. Neuzil J., Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 269:1994;16712-16719.
37. Amiel S.A., Caprio S., Sherwin R.S., Plewe G., Haymond M.W., Tamborlane W.T. Insulin resistance of puberty a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab. 72:1991;277-282.